Karl Hård

Karl Hård

Investor Relations Contact at EGETIS THERAPEUTICS AB

Net worth: 99 420 $ as of 30/05/2026

64 year
Health Technology
Consumer Services

Profile

Karl J.
Hård
is currently VP-Investor Relations & Business Development at Egetis Therapeutics AB since 2022.
Former positions include Investor Relations Contact at AstraZeneca PLC, Assistant Professor at the University of Leiden, Head-Investor Relations & Corporate Communications at Redx Pharma Plc from 2016 to 2017, and Head-Investor Relations & Communications at Kiadis Pharma NV from 2017 to 2018.
Education includes a doctorate from the University of Utrecht and graduate studies at the University of Helsinki.

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
30/12/2025 150,982 ( 0.03% ) 99 420 $ 30/05/2026

Karl Hård active positions

CompaniesPositionStart
EGETIS THERAPEUTICS AB Investor Relations Contact 31/01/2022

Former positions of Karl Hård

CompaniesPositionEnd
KIADIS PHARMA N.V. Investor Relations Contact 30/12/2018
REDX PHARMA LTD Investor Relations Contact 01/07/2017
Corporate Officer/Principal -
ASTRAZENECA PLC Public Communications Contact -
See the detail of Karl Hård's experience

Training of Karl Hård

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

13

1st degree connections

7

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies7

Health Technology

Consumer Services

Consumer Services

Consumer Services

Health Technology

Health Technology

Health Technology